Our search for novel compounds that selectively affect the survival of MLL-r leukemia cells yielded CCI-006 and CCI-007 that largely target an identical subset of MLL-r and CALM-AF10 translocated leukemia cell lines. This evidence concerns the gene MLLT10 and leukemia.